Pediatric Radiology

, Volume 40, Issue 11, pp 1768–1773

Radiological findings of community-acquired methicillin-resistant and methicillin-susceptible Staphylococcus aureus pediatric pneumonia in Hawaii

  • Guliz Erdem
  • Lora Bergert
  • Kyra Len
  • Marian Melish
  • Kevin Kon
  • Robert DiMauro
Original Article



Community-acquired Staphylococcus aureus (CA-SA) infections are common among pediatric patients in Hawaii.


We wanted to characterize the radiological features of methicillin-susceptible (CA-MSSA) and methicillin-resistant (CA-MRSA) staphylococcal pneumonia in Hawaiian children.

Materials and methods

We retrospectively reviewed medical records and imaging studies of children with SA pneumonia identified from 1996 through 2007.


Of 40 children, 26 (65%) had CA-MRSA pneumonia and 14 patients (35%) had CA-MSSA pneumonia. CA-MRSA patients were significantly younger than CA-MSSA patients (65% younger than 1 year vs. 36% older). In a majority (62%) of CA-MRSA patients, the consolidation was unilateral; in most of the CA-MSSA cases (79%), the consolidation was bilateral. Fifty percent of the patients with CA-MRSA and 21% of those with CA-MSSA had pneumatoceles (P = 0.1). CA-MRSA patients more commonly had pleural effusions (85% vs. 64% for CA-MSSA) and pleural thickening (50% vs. 36% for CA-MSSA).


This case series describes the radiologic characteristics of CA-MRSA and CA-MSSA pneumonia in children in a highly endemic area. We found that CA-MRSA pneumonias are unilateral in a majority of pediatric pneumonia cases, are more common in children 1 year or younger, and have higher rates of complications in comparison to CA-MSSA patients.


Staphylococcus aureus Pneumonia Children Methicillin resistance 


  1. 1.
    Boyce JM, Causey WA (1982) Increasing occurrence of methicillin-resistant Staphylococcus aureus in the United States. Infect Control 3:377–383PubMedGoogle Scholar
  2. 2.
    Jarvis WR, Thornsberry C, Boyce J et al (1985) Methicillin-resistant Staphylococcus aureus at children’s hospitals in the United States. Pediatr Infect Dis J 4:651–655CrossRefGoogle Scholar
  3. 3.
    Salgado CD, Farr BM, Calfee DP (2003) Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 36:131–139CrossRefPubMedGoogle Scholar
  4. 4.
    Dietrich DW, Auld DB, Mermel LA (2004) Community-acquired methicillin-resistant Staphylococcus aureus in southern New England children. Pediatrics 113:E347–E352CrossRefPubMedGoogle Scholar
  5. 5.
    Frank AL, Marcinak JF, Mangat PD et al (1999) Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children. Pediatr Infect Dis J 18:993–1000CrossRefPubMedGoogle Scholar
  6. 6.
    Groom AV, Wolsey DH, Naimi TS et al (2001) Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 286:1201–1205CrossRefPubMedGoogle Scholar
  7. 7.
    Herold BC, Immergluck LC, Maranan MC et al (1998) Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279:593–598CrossRefPubMedGoogle Scholar
  8. 8.
    Maguire GP, Arthur AD, Boustead PJ et al (1996) Emerging epidemic of community-acquired methicillin-resistant Staphylococcus aureus infection in the Northern Territory. Med J Aust 164:721–723PubMedGoogle Scholar
  9. 9.
    Roghman M (2000) Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcal aureus bacteremia. Arch Intern Med 160:1001–1004CrossRefGoogle Scholar
  10. 10.
    Shurland S, Zhan M, Bradham DD et al (2007) Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcal aureus. Infect Control Hosp Epidemiol 28:273–279CrossRefPubMedGoogle Scholar
  11. 11.
    Cosgrove SE, Qi Y, Kaye KS et al (2005) The impact of methicillin resistance in Staphylococcal aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 26:166–174CrossRefPubMedGoogle Scholar
  12. 12.
    Cosgrove SE, Sakoulas G, Perencevich EN et al (2003) Comparison of mortality-associated methicillin-resistant and methicillin-susceptible Staphylococcal aureus bacteremia: a meta-analysis. Clin Infect Dis 36:53–59CrossRefPubMedGoogle Scholar
  13. 13.
    Bartlett JG, Mundy LM (1995) Community acquired pneumonia. NEJM 333:1618–1624CrossRefPubMedGoogle Scholar
  14. 14.
    Centers for Disease Control and Prevention (1999) Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus—Minnesota and North Dakota, 1997–1999. JAMA 282:1123–1125CrossRefGoogle Scholar
  15. 15.
    Fridkin SK, Hageman JC, Morrison M et al (2005) Methicillin-resistant Staphylococcus aureus disease in three communities. New Engl J Med 352:1436–1444CrossRefPubMedGoogle Scholar
  16. 16.
    Francis JS, Doherty MC, Lopatin U et al (2005) Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 40:100–107CrossRefPubMedGoogle Scholar
  17. 17.
    Hageman JC, Uyeki TM, Francis JS et al (2006) Severe community-acquired pneumonia due to Staphylococcus aureus, 2003–04 influenza season. Emerg Infect Dis 12:894–899PubMedGoogle Scholar
  18. 18.
    Centers for Disease Control and Prevention (2007) Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza—Louisiana and Georgia, December 2006-January 2007. MMWR 56:325–329Google Scholar
  19. 19.
    Micek ST, Dunne M, Kollef MH (2005) Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production. Chest 128:2732–2738CrossRefPubMedGoogle Scholar
  20. 20.
    Frazee BW, Salz TO, Lambert L et al (2005) Fatal community-associated methicillin-resistant Staphylococcus aureus pneumonia in an immunocompetent young adult. Ann Emerg Med 46:401–404CrossRefPubMedGoogle Scholar
  21. 21.
    Fergie J, Purcell K (2002) Community-acquired methicillin-resistant Staphylococcus aureus infections in South Texas children. Pediatr Infect Dis J 20:860–863Google Scholar
  22. 22.
    Johnston BL (1994) Methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia—a critical review. Semin Respir Infect 9:199–206PubMedGoogle Scholar
  23. 23.
    Ibia E (2005) Methicillin-resistant Staphylococcus aureus pneumonia in children: a call for increased vigilance. South Med J 98:1059–1060CrossRefPubMedGoogle Scholar
  24. 24.
    Gillet Y, Issartel B, Vanhems P et al (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotizing pneumonia in young immunocompetent patients. Lancet 359:753–759CrossRefPubMedGoogle Scholar
  25. 25.
    Nguyen ET, Kanne JP, Hoang LP et al (2008) Community-acquired methicillin-resistant Staphylococcus aureus pneumonia: radiographic and computed tomography findings. J Thorac Imaging 23:13–19CrossRefPubMedGoogle Scholar
  26. 26.
    Gonzalez C, Rubio M, Romera-Vivas J et al (1999) Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 29:1171–1177CrossRefPubMedGoogle Scholar
  27. 27.
    Centers for Disease Control and Prevention (2004) Community-associated methicillin-resistant Staphylococcus aureus infections in Pacific Islanders—Hawaii, 2001–2003. MMWR 53:767–770Google Scholar
  28. 28.
    Estivariz CF, Park SY, Hageman JC et al (2007) Emergence of community-associated methicillin-resistant Staphylococcus aureus in Hawaii, 2001–2003. J Infect 54:349–357CrossRefPubMedGoogle Scholar
  29. 29.
    Canty TG, Goscienski P, Edwards D et al (1978) Staphylococcal pneumonia. West J Med 129:201–209PubMedGoogle Scholar
  30. 30.
    Schultz KD, Fan LL, Pinsky J et al (2004) The changing face of pleural empyemas in children: epidemiology and management. Pediatrics 113:1735–1740CrossRefPubMedGoogle Scholar
  31. 31.
    Ochoa TJ, Mohr J, Wanger A et al (2005) Community-associated methicillin-resistant Staphylococcal aureus in pediatric patients. Emerg Infec Dis 11:966–968Google Scholar
  32. 32.
    Martinez-Aguilar G, Hammerman WA, Mason EO et al (2003) Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcal aureus in children. Pediatr Infect Dis J 22:593–598CrossRefPubMedGoogle Scholar
  33. 33.
    Tenover FC, Goering RV (2009) Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J Antimicrob Chemother 64:441–446CrossRefPubMedGoogle Scholar
  34. 34.
    Bubeck Wardenburg J, Palazzolo-Ballance AM, Otto M et al (2008) Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J Infect Dis 198:1166–1170CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Guliz Erdem
    • 1
  • Lora Bergert
    • 1
  • Kyra Len
    • 1
  • Marian Melish
    • 1
  • Kevin Kon
    • 2
  • Robert DiMauro
    • 2
  1. 1.Department of PediatricsUniversity of Hawaii, John A. Burns School of MedicineHonoluluUSA
  2. 2.Department of RadiologyKapiolani Medical Center for Women and ChildrenHonoluluUSA

Personalised recommendations